| 标题： | 乳腺恶性肿瘤相关心脏毒性事件的中医证候诊断标准 |
| title： | Diagnostic Criteria for Traditional Chinese Medicine Syndromes of Cardiac Toxicity Events in Breast Cancer Patients |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊断 |
| field： | Diagnosis |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 中医师、西医师、中西医结合医师 |
| Guide users： | Physicians of traditional Chinese medicine, western medicine, and integrated traditional Chinese and western medicine |
| 证据分级方法： | 采用推荐意见分级的评估、制定及评价（grading of recommendations assessment, development and evaluation, GRADE）系统对证据级别及其推荐级别进行分类。考虑中医证候等内容的特殊性，将结合专家认可度做调整。 |
| Evidence grading method： | Grading of recommendations assessment, development and evaluation（GRADE）. And considering the special nature of TCM syndromes and the importance of expert recognition, adjustments will be made in conjunction with the level of expert endorsemen. |
| 制定单位： | 中华中医药学会心血管病分会、上海市中医药学会乳腺病分会，上海中医药大学附属龙华医院 |
| Formulating unit： | Cardiovascular Disease Branch of China Association of Chinese Medicine,Shanghai Association of Traditional Chinese Medicine for Breast Diseases, and Longhua Hospital Affiliated with Shanghai University of Traditional Chinese Medicine. |
| 注册时间： | 2024-10-23 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN905 |
| Registration number： | |
| 指南制订的目的： | 在乳腺癌患者中，尤其是那些合并心血管疾病风险的个体，形成一项有关中医证候诊断标准的专家共识，对于指导临床医务工作者识别心脏毒性风险、优化抗肿瘤治疗方案至关重要。这一共识不仅提升患者治疗依从性和生活质量，还促进了多学科治疗团队(MDT)的协作，加强了不同专业医师间的信息共享和协同工作，从而提高治疗效果并推动医学进步。中医证候诊断标准的共识制定对于乳腺癌治疗具有重要意义，它有助于提高治疗的针对性和有效性，减少不良反应，改善患者的生活质量，并为乳腺癌相关心脏毒性事件风险人群的预后评估提供参考。此外，共识的制定为临床研究提供了标准化评估工具，增强了研究的质量和可靠性。 |
| Purpose of the guideline： | n patients with breast cancer, especially those with the risk of cardiovascular diseases, forming an expert consensus on the diagnostic standards of TCM syndrome is crucial for guiding clinical medical workers to identify the risk of cardiac toxicity, optimize anti-tumor treatment plans, and improve patient treatment compliance and quality of life. This consensus not only enhances patient treatment compliance and quality of life but also promotes multidisciplinary treatment team (MDT) collaboration, strengthens information sharing and collaborative work among physicians of different specialties, thereby improving treatment outcomes and advancing medical progress. The consensus on TCM syndrome diagnostic standards is of great significance for the treatment of breast cancer. It helps to improve the specificity and effectiveness of treatment, reduce adverse reactions, improve the quality of life for patients, and provide a reference for the prognosis assessment of populations at risk of breast cancer-related cardiac toxicity events. In addition, the formulation of the consensus provides standardized assessment tools for clinical research, enhancing the quality and reliability of research. |
